Parnell Pharma Cash Flow - Annual (OTCMKTS:PARNF)

Add to My Stocks
$0.2 $0.05 (20%) PARNF stock closing price Jun 19, 2018 (Closing)

The financial analysis of PARNF requires an investor to check the cash flows for Parnell Pharma. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Parnell Pharma profits one has to check the income statement and for Parnell Pharma debt one has to check the balance sheet. The cash flow statement is essetial while conducting the Parnell Pharma cash flow analysis and can be used to measure the operating performance of Parnell Pharma compared to various industry peers like SUWN stock and ACUR stock. PARNF decrease in investments stood at a value of $-3.77M for the latest year 2016.

View details of Parnell Pharma cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec201620152014
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow1.95M1.11M-
Net Increase (Decrease) in Assets Liabilities3.12M-1.7M-
Cash From (used in) Discontinued Operations---
Other Adjustments Net2.05M-1.42M-7.98M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.41M-1.3M-0.87M
Acquisition Disposition of Subsidiaires---
Increase (Decrease) in Investments---
Other Cash Inflow (Outflow) from Investment Activities-3.36M-4.63M-0.67M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares6.72M--0.52M
Issuance (Repayment) of Debt Securities--1.09M-
Increase (Decrease) in Bank & Other Borrowings9.04M10.23M-
Payment of Dividends & Other Cash Distributions---
Other Cash from (used by) Financing Activities-0.92M-0.03M-0.09M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-0.97M1.54M17.8M
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year4.21M11.9M17.8M
Cash & Equivalents at Year End5.29M4.26M4.98M
All figures in USD. M: Millions of USD, B: Billions of USD.

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Parnell Pharma stock price history and Parnell Pharma stock comparison chart inevitably reflect its cash flow situation.

  • Parnell Pharma has cash of $5.29M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Parnell Pharma stock price.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-9.01M for PARNF.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-3.77M for PARNF stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Parnell Pharma earned $14.84M from financing activities, in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Parnell Pharma Cash Flow

Annual Cash Flow Statements For Parnell Pharmaceuticals Holdings Ltd Peers

Amerisourcebergen cash flow, Acura Pharma cash flow, China Medicine cash flow, GlobeImmune cash flow, Sunwin Stevia cash flow